Martin Gering

Martin Gering

Auto-generated profile, based on publicly available information

Martin Gering

Institute of Genetics, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 1998 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MGM. Gering
M. Gering
ARA.R.F. Rodaway
A.R.F. Rodaway
BGB. Göttgens
B. Göttgens
RPR.K. Patient
R.K. Patient
AGA.R. Green
A.R. Green
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 March 2005 in Developmental Cell
Verified
Journal Article
Closed access
MGMartin Gering
Martin Gering
RPRoger Patient
Roger Patient

22 December 2003 in Development
Verified
Journal Article
Closed access
PDF file
MGMartin Gering
Martin Gering
YYYoshihiro Yamada
Yoshihiro Yamada
TRTerence Rabbitts
Terence Rabbitts
RPRoger K. Patient
Roger K. Patient
The LIM domain protein Lmo2 and the basic helix-loop-helix transcription factor Scl/Tal1 are expressed in early haematopoietic and endothelial progenitors and interact with each other in haematopoietic cells. While loss-of-function studies have shown that Lmo2 and Scl/Tal1 are essential for haematopoiesis and angiogenic remodelling of the vasculature, gain-of-function studies have suggested an earlier role for Scl/Tal1 in the specification of haemangioblasts, putative bipotential precursors of blood and endothelium. In zebrafish embryos, Scl/Tal1 can induce these progenitors from early mesoderm mainly at the expense of the somitic paraxial mesoderm. We show that this restriction to the somitic paraxial mesoderm correlates well with the ability of Scl/Tal1 to induce ectopic expression of its interaction partner Lmo2. Co-injection of lmo2 mRNA with scl/tal1 dramatically extends its effect to head, heart, pronephros and pronephric duct mesoderm inducing early blood and endothelial genes all along the anteroposterior axis. Erythroid development, however, is expanded only into pronephric mesoderm, remaining excluded from head, heart and somitic paraxial mesoderm territories. This restriction correlates well with activation of gata1 transcription and co-injection of gata1 mRNA along with scl/tal1 and lmo2 induces erythropoiesis more broadly without ventralising or posteriorising the embryo. While no ectopic myeloid development from the Scl/Tal1-Lmo2-induced haemangioblasts was observed, a dramatic increase in the number of endothelial cells was found. These results suggest that, in the absence of inducers of erythroid or myeloid haematopoiesis, Scl/Tal1-Lmo2-induced haemangioblasts differentiate into endothelial cells.

1 June 2009 in Developmental Cell
Verified
Journal Article
Closed access
RWRobert N. Wilkinson
Robert N. Wilkinson
CPClaire Pouget
Claire Pouget
MGMartin Gering
Martin Gering
ARAngela Russell
Angela Russell
SDStephen G. Davies
Stephen G. Davies
RPRoger Patient
Roger Patient

15 December 2006 in Development
Verified
Journal Article
Open access
PDF file
NMNatalia Meier
Natalia Meier
SKSanja Krpic
Sanja Krpic
PRPatrick Rodriguez
Patrick Rodriguez
John StrouboulisJohn Strouboulis
John Strouboulis
Maria MontiMaria Monti
Maria Monti
FGFrank Grosveld
Frank Grosveld
Ldb1, a ubiquitously expressed LIM domain binding protein, is essential in a number of tissues during development. It interacts with Gata1, Tal1, E2A and Lmo2 to form a transcription factor complex regulating late erythroid genes. We identify a number of novel Ldb1 interacting proteins in erythroleukaemic cells, in particular the repressor protein Eto-2 (and its family member Mtgr1), the cyclin-dependent kinase Cdk9, and the bridging factor Lmo4. MO-mediated knockdowns in zebrafish show these factors to be essential for definitive haematopoiesis. In accordance with the zebrafish results these factors are coexpressed in prehaematopoietic cells of the early mouse embryo,although we originally identified the complex in late erythroid cells. Based on the change in subcellullar localisation of Eto-2 we postulate that it plays a central role in the transition from the migration and expansion phase of the prehaematopoietic cells to the establishment of definitive haematopoietic stem cells.

1 May 2005 in Blood
Verified
Journal Article
Closed access
LPLucy J. Patterson
Lucy J. Patterson
MGMartin Gering
Martin Gering
RPRoger Patient
Roger Patient
Blood and endothelial cells arise in close association in developing embryos, possibly from a shared precursor, the hemangioblast, or as hemogenic endothelium. The transcription factor, Scl/Tal1 (stem cell leukemia protein), is essential for hematopoiesis but thought to be required only for remodeling of endothelium in mouse embryos. By contrast, it has been implicated in hemangioblast formation in embryoid bodies. To resolve the role of scl in endothelial development, we knocked down its synthesis in zebrafish embryos where early precursors and later phenotypes can be more easily monitored. With respect to blood, the zebrafish morphants phenocopied the mouse knockout and positioned scl in the genetic hierarchy. Importantly, endothelial development was also clearly disrupted. Dorsal aorta formation was substantially compromised and gene expression in the posterior cardinal vein was abnormal. We conclude that scl is especially critical for the development of arteries where adult hematopoietic stem cells emerge, implicating scl in the formation of hemogenic endothelium.